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Edited by Peter BrzezinskiAbstract Although the a-helical Y(X)4L/ containing region of
eIF4E-binding protein (4EBP) is the major binding region with
eukaryotic initiation factor 4E (eIF4E), the roles of its N- and
C-terminal regions in the binding are hardly known. To clarify
the roles of these ﬂexible regions in the interaction, the binding
features of the sequentially N-, C-, or both-terminal-residue-de-
leted 4EBP2 mutants were investigated by surface plasmon res-
onance (SPR) analysis. It was shown that the C-terminal His74-
Glu89 sequence has an auxiliary, but indispensable, function in
stabilizing the binding to eIF4E. The possible interaction with
eIF4E was estimated by molecular dynamics simulation. This
is the ﬁrst report on the importance of the C-terminal ﬂexible re-
gion in the eIF4E-binding regulation of 4EBP.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The control of mRNA translation at the level of initiation
is critical for gene expression in mammalian cells [1]. Eukary-
otic initiation is performed by many eukaryotic initiation fac-
tors (eIFs) and regulated through changes in the
phosphorylation states of eIFs and endogenous regulator
proteins [2]. One of the main regulatory steps in translation
initiation involves the formation of the eukaryotic initiation
factor 4F (eIF4F) complex. eIF4F is a supramolecular com-
plex of three subunits, eIF4E, eIF4A and eIF4G, and is re-
quired to recruit ribosomal subunits to the mRNA during
cap-dependent initiation [3]. In the ﬁrst initiation step in
the cap-dependent translation of mRNA, the selective recog-
nition of a 7-methylated guanine (m7G) cap structure cova-
lently attached to the 5 0 terminus of mRNA by eIF4E is
required. Thus, eIF4E serves as a master switch that controls
eukaryotic translation, because the initiation function of
eIF4E is controlled by the association/dissociation with the
endogenous 4E-binding protein (4EBP) [2,4,5].*Corresponding author. Fax: +81 72 690 1068.
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doi:10.1016/j.febslet.2008.09.003The regulation of the eIF4E function by 4EBP is per-
formed by the competition with eIF4G in a common interac-
tion region of eIF4E [6–8] and is thus critical for the proper
control of protein biosynthesis. At present, the following is
known: (i) 4EBP has three isoforms (4EBP1–4EBP3) [2,4].
(ii) These isoforms bind eIF4E through a motif of the se-
quence Y(X)4L/ (X: variable, /: hydrophobic, see Fig. 1a)
[7,8]. (iii) The hyperphosphorylations of their Thr and Ser
residues in response to growth factors and mitogens result
in their release from eIF4E [5,9]. (iv) When they coexist with
eIF4E, the binding-motif region forms a helical structure and
binds to a conserved surface on the dorsal side of the eIF4E
cap-binding pocket [10].
To clarify the structural feature of the 4EBP-binding site of
eIF4E in its cap-bound state, we previously analyzed the crys-
tal structure of the ternary complex of the m7GpppA–eIF4E–
4EBP1 peptide (corresponding to Thr36-Thr70 sequence) [11].
However, the regulatory function of eIF4E by 4EBP has not
yet been satisfactorily elucidated at the atomic level, because
the N- and C-terminal sequences remain unstructured or struc-
turally ﬂexible. On the other hand, it was shown previously
that the N-terminal region of eIF4E, despite its structural ﬂex-
ibility and lack of contribution to the ternary structural forma-
tion of eIF4E, primarily participates in the conformational
coupling between eIF4E and eIF4G, thus enhancing ribosome
loading onto the mRNA cap [12]. Also, in recent years, the
functional importance of the ﬂexible sequence has received
much attention [13].
In this work, we investigated the function of the N- and C-
terminal ﬂexible sequences of 4EBP2 for the interaction with
eIF4E; 4EBP2 was selected because it has the longest sequence
and exhibits the strongest interaction among the three 4EBP
isoforms [14]. The N- and C-terminal regions of 4EBP2 were
deﬁned as the up- and down-stream sequences from the a-heli-
cal Y(X)4L/ motif-containing central region (Thr46-Thr70),
respectively. Using the sequentially N-, C- or both-terminal-
residue-deleted 4EBP2 mutant (Fig. 1b), the kinetic parameter
on the interaction with m7GTP-bound eIF4E was estimated by
surface plasmon resonance (SPR) measurement. Conse-
quently, it was suggested that the C-terminal ﬂexible region
of 4EBP, but not the N-terminal one, plays an important role
in the interaction with eIF4E. This is the ﬁrst report on the
function of the 4EBP C-terminal ﬂexible region and is impor-
tant to understand the binding regulation of the eIF4E by the
4EBP isoform.blished by Elsevier B.V. All rights reserved.
Fig. 1. (a) Amino acid sequences of 4EBP13 isoforms and (b) schematic representation and naming of the sequentially N-, C- or both-terminal
terminal-residue-deleted human 4EBP2 mutants. The sequences of 4EBP isoform in (a) are aligned on the basis of their functional similarities. The
eIF4E-binding Y(X)4L/ sequence and His74-Glu89 of 4EBP2 or its corresponding sequence of 4EBP1 or 4EBP3 are shown in blue and red,
respectively. The 609–660 sequence of human eIF4GI is also shown for comparison. The Thr46-Glu89 sequence of 4EBP2 is underlined. The eIF4E-
binding Y(X)4L/ and His74-Glu89 regions of 4EBP2 in (b) are shown by blue and red boxes, respectively.
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2.1. Peptides
The respective peptides corresponding to the Thr46-Thr70 and
His74-Glu89 sequences of 4EBP2 and the Gly632-Thr647 sequence
of eIF4GI were synthesized using a solid-phase peptide synthesizer.
These peptides were characterized by mass spectrometry and found
to be of >99.0% purity, as assessed by reverse-phase HPLC. The pre-
dicted and measured masses were 2907.32 and 2907.40 Da for Thr46-
Thr70, 1644.85 and 1646.44 Da for His74-Glu89, and 1706.94 and
1708.45 Da for Gly632-Thr647, respectively. The concentration of
peptide for the experiment was adjusted by the weighed amount.
2.2. Preparation of full-length and deleted 4EBP2
The gene expression in Escherichia coli, isolation and puriﬁcation of
N-terminal-GST- fused human full-length 4EBP2 were performed as
described in the literature [15], in which buﬀer A [1 mM ED-
TA,100 mM NaCl, and 50 mM Tris–HCl (pH8.0)] was used for the
sample preparation. The scission of GST was then performed using
a PreScission Protease kit (GE Healthcare) and the resulting GST-free
4EBP was separated by gel chromatography.
The gene encoding N-terminal 12, 32 or 45 residue-deleted or C-ter-
minal 9, 31, 47 or 55 residue-deleted 4EBP2 mutant (abbreviated as
Nd12-, Nd32-, Nd45-, Cd9-, Cd31-, Cd47-, and Cd55-4EBP2, respec-
tively (Fig. 1b) was constructed by PCR using a primer designed for
producing each deleted gene. These mutant genes which sequences
were veriﬁed by DNA sequencer (ABI Prism 310 genetic analyzer, Ap-
plied Biosystems) were inserted into the pET23b vector and trans-
formed in the BL21(DE3) cell. The N-terminal 45 and C-terminal 31residue-deleted 4EBP2 (Nd45/Cd31-4EBP2), which corresponds to
the Thr46-Glu89 sequence, was also prepared according the combina-
tion of the above N- and C-terminal-residue-deletion methods. The
purities of the samples were conﬁrmed as single bands (>90%) under
reducing condition by SDS–PAGE.
2.3. Preparation of m7GTP-bound eIF4E
The gene construction, expression and puriﬁcation of full-length
eIF4E in E. coli were performed according to previous reports
[14,16]. The supernatant containing the recombinant protein was ap-
plied to an m7GTP-Sepharose 4B aﬃnity column equilibrated with
buﬀer B [20 mMHEPES–KOH (pH 7.5), 1 mM DTT, 0.1 mM EDTA,
and 100 mMKCl]. The m7GTP complex of eIF4E was prepared by the
elution with buﬀer C (buﬀer B + 100 lMm7GTP). The eluted solution
was concentrated with Centricon 10 (Millipore) to the desired concen-
tration, which was determined by the Bradford method. The purity of
the sample was conﬁrmed as single band (>90%) by SDS–PAGE.
2.4. SPR analysis
A binding assay was performed using BIAcore X (GE Healthcare).
The full-length 4EBP2 or its residue-deleted mutant, as a ligand mole-
cule, was immobilized on a CM5 sensor chip by the amine-coupling
method, according to the manufacturers instructions, in which
10 lg/ml protein was reacted in 10 mM sodium acetate buﬀer (pH
4.5) and the concentration of the immobilized protein was adjusted
to about 150 RU within the range recommended for the accurate mea-
surement of the kinetic parameters [17]. M7GTP-bound eIF4E, as an
analyte molecule, was then injected as a function of the concentration.
Each cycle consisted of 40 lL injection of the indicated amount of
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7.4), 150 mM NaCl, 3 mM EDTA, and 0.05% Surfactant P-20). The
chip was regenerated after each cycle by washing three times with
10–20 lL of 2 M NaCl and ﬁve times with 15 lL of the running buﬀer.
The measurement was performed at a ﬂow rate of 20 lL/min at 25 C.
The obtained sensorgram was evaluated using the BIA evaluation soft-
ware package, through which the response from the unimmobilized
ﬂow cell as a reference was subtracted from the sample response to ob-
tain the sensorgram for a speciﬁc interaction. The constants for asso-
ciation rate, kon, and dissociation rate, koﬀ, and the equilibrium
constant for dissociation, KD (=koﬀ/kon), were obtained using 1:1
(Langmuir) binding analysis; the sensorgram was also analyzed by
two-state reaction model, because it could be thought that the frag-
ment of 4EBP undergoes disorder-to-order transition to form helical
structure in the complex with eIF4E [11], and no notable diﬀerence
was observed. For the SPR spectra showing fast association and disso-
ciation rates, their KD values were obtained using static Scatchard
aﬃnity analysis. The respective values were checked for consistency
using local ﬁtting for each analyte concentration.
2.5. Molecular dynamics simulation
To estimate where and how the C-terminal His74-Glu89 sequence of
4EBP2 binds to molecular surface of eIF4E, the MD simulations were
performed for an aqueous solution system of m7GpppA-bound
eIF4E–4EBP2 Pro47-Glu89 sequence complex; the structure was built
from the X-ray crystal structure of m7GpppA–eIF4E–4EBP1 peptide
(PDB ﬁle:1WKW) and the atomic coordinate of the undetermined
Met67-Glu88 sequence was constructed manually on a graphics com-
puter, by referring to the solution structure of the yeast m7GDP-bound
eIF4E–eIF4G fragment (393–490) complex (PDB ﬁle: 1RF8) [12].
Assuming a neutral pH (7.0) of the system, the MD simulation was
performed for 3 ns in the same manner as the previous paper [11] by
using the AMBER 6 program [18].3. Results and discussion
The SPR sensorgrams of full-length, Nd45-, Cd31-, Cd47-,
and Nd45/Cd31-4EBP2s and the calculated ﬁtting curves by0
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Fig. 2. Experimental SPR sensorgrams (grey-colored wide lines) and calcu
4EBP2—m7GTP-bound eIF4E pairs by 1:1 (Langmuir) binding model, togeth
SPR signal shows the time response of the addition of eIF4E to 4EBP2
sensorgram). The right and left parts of each sensorgram indicate the phase
respectively.1:1 (Langmuir) binding model are shown in Fig. 2; the SPR
proﬁles of Nd12- and Nd32-, Cd9-, and Cd59-4E-BP2s are
not shown, because of the nearly same as those of Nd45-,
Cd31-, and Cd47-4EBP2s, respectively. The comparison with
the calculated ﬁtting curves by two-state reaction model
showed no notable diﬀerence (Supplementary data), suggesting
that the Y(X)4L/ helical conformation of 4EBP is formed con-
currently with the binding (one-step process). The sensorgrams
show the on- and oﬀ-rates of 4EBP2 for the binding with
m7GTP-bound eIF4E and exhibit considerable diﬀerence be-
tween the N- and C-terminal-residue deletions. The kon, koﬀ
and KD values obtained by SPR analysis are given in Table
1, in which the data on the peptides of Thr46-Thr70 (including
Y(X)4L/ binding motif) and His74-Glu89 sequences of 4EBP2
and of Gly632-Thr647 sequence of eIF4GI are given for the
comparison. The KD value of 4EBP2–eIF4E pair is in the
range of 4EBP1–eIF4E pair [19], although an approximate
10-fold diﬀerence is observed from the previously reported va-
lue of 4EBP2–eIF4E pair [14], owing to the diﬀerent experi-
mental condition.
3.1. N-Terminal ﬂexible region of 4EBP2 for the interaction
with eIF4E
Concerning the role of the N-terminal ﬂexible region of
4EBP2 in the interaction with eIF4E, the SPR kinetic param-
eters showed no notable contribution of the N-terminal 1–45
sequence to the interaction, because all SPR sensorgrams
showed similar proﬁles despite the diﬀerence in the length of
deletion, where the kon and koﬀ values were on similar orders
of 105 and 104, respectively, and the KD values of Nd12-,
Nd32- and Nd45-4EBP2 are on the same order as that of
full-length 4EBP2, indicating that the function of the 4EBP
N-terminal ﬂexible region is not to stabilize the interaction0
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lated ﬁts (red lines) of full-length, Nd45-, Cd-31-, and Nd45/Cd31-
er with sensorgrams of Cd47-4EBP2– and peptide 1–eIF4E pairs. Each
mutant as a function of concentration of eIF4E (indicated in each
s of injection of eIF4E and exposure of the chip to eIF4E-free buﬀer,
Table 1
SPR kinetic parameters of full-length 4EBP2 and its N-, C- or both-terminal-residue-deleted mutants with m7GTP-bound eIF4E at 25 Ca,b
4EBP2 mutant m7GTP-bound eIF4E ka (1/M s) kd (1/s) KD (M)
Full-length Full-length 2.42 ± 0.05 · 105 6.63 ± 0.42 · 104 2.74 ± 0.23 · 109
Nd12-4EBP2 Full-length 3.18 ± 0.04 · 105 3.38 ± 0.25 · 104 1.20 ± 0.10 · 109
Nd32-4EBP2 Full-length 1.63 ± 0.02 · 105 5.43 ± 0.40 · 104 3.33 ± 0.28 · 109
Nd45-4EBP2 Full-length 1.70 ± 0.02 · 105 7.61 ± 0.28 · 104 4.48 ± 0.22 · 109
Cd9-4EBP2 Full-length 3.07 ± 0.03 · 105 2.84 ± 0.41 · 104 9.23 ± 1.41 · 1010
Cd31-4EBP2 Full-length 1.15 ± 0.03 · 105 3.75 ± 0.23 · 104 3.26 ± 0.28 · 109
Cd47-4EBP2 Full-length – – 1.88 ± 0.30 · 106
Cd55-4EBP2 Full-length – – 4.21 ± 0.79 · 106
Nd45/Cd31-4EBP2 Full-length 1.55 ± 0.05 · 105 8.79 ± 0.44 · 104 5.65 ± 0.45 · 109
Peptide I Full-length – – 2.21 ± 0.21 · 106
Peptide II Full-length n.d. n.d. n.d
PEPTIDE III Full-length n.d. n.d. n.d.
Peptide I: Thr46-Thr70 (4EBP2), peptide II: His74-Glu89 (4EBP2), peptide III: Gly632-Thr647 (eIF4GI).
aThe kinetic parameters were estimated using the 1:1 (Langmuir) binding model. The KD (M) values of Cd47-4EBP2, Cd55-4EBP2 and peptide I were
estimated using static Scatchard aﬃnity model.
bThe KD (M) value of full-length 4EBP2—eIF4E pair using Scatchard model was 3.4 ± 1.9 · 109, and no notable diﬀerence was observed from the
value using the Langmuir model.
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minal region of 4EBP1 or 4EBP2 is necessary for optimal reg-
ulation of the insulin-simulated phosphorylation [20].
3.2. C-Terminal ﬂexible region of 4EBP2 is important for
interaction with eIF4E
A contrast response was observed for the C-terminal-resi-
due-deleted 4EBP2. As is clear from the comparison between
the SPR sensorgrams of Cd31- and Cd47-4EBP2s (Fig. 2),
the characteristic diﬀerence is observed and this is in contrast
with nearly the same sensorgrams between Cd9- and Cd31-
4EBP2s and between Cd47 and Cd55-4EBP2s. In the Cd47-
4EBP2 and Cd55-4EBP2—eIF4E interaction pairs, the associ-
ation and dissociation rates are too fast to estimate their values
exactly by 1:1 (Langmuir) binding analysis, indicating that the
deﬁcit in this C-terminal region changes the mode of interac-
tion with eIF4E signiﬁcantly, as compared with the presence
of this region. Thus the KD values were estimated by static
Scatchard aﬃnity analysis, and the best-ﬁtted values showed
that the deletion of more than C-terminal 47 residues of
4EBP2 weakens the interaction with eIF4E by more than three
orders of magnitude, compared with the full-length 4EBP2. In
contrast, the C-terminal deletion of less than 31 residues
showed nearly the same kinetic parameters as those of full-
length 4EBP2. This marked diﬀerence between their KD values
indicates that the 32–47 sequence from the C-terminus (corre-
sponding to His74-Glu89 sequence) primarily participates in
the interaction with eIF4E (also see Fig. 1). This diﬀerence
would be mainly due to the high-aﬃnity eﬀect (decreased kd)
of 4EBP2 His74-Glu89 sequence for eIF4E, thus delaying dis-
sociation, because the nearly same ka values of 105 are kept
regardless of the diﬀerent deletion length of 4EBP2.
3.3. Auxiliary, but important, role of His74–Glu89 sequence in
eIF4E binding
The C-terminal ﬂexible His74-Glu89 region of 4EBP2 was
shown to be an important sequence for the interaction with
eIF4E. To examine how strong this sequence interacts with
eIF4E compared with the Y(X)4L/ sequence, the kinetic
parameters of peptide I (Thr46-Thr70) and peptide II
(His74-Glu89) for the interaction with eIF4E were measured(Table 1). Consequently, the peptide I–eIF4E pair showed dis-
sociation on the order of 107, the association of which was
about three orders of magnitude weaker than that of Cd31-
4EBP2. Although this diﬀerence may not exactly reﬂect the
strength of the interaction because of diﬀerent length of the
mutant sequence, similar order of 106–107 has been esti-
mated by ﬂuorescence method [21,22], in which the origin of
the interaction is due to the interaction between Trp73 of
eIF4E and amino acid of the peptide I. Therefore, it would
say that the His74-Glu89 sequence of 4EBP2 plays an impor-
tant role in strengthening the eIF4E-binding via the Y(X)4L/
sequence. In fact, this could be suggested from the kinetic
parameters of the Nd45/Cd31-4EBP2–eIF4E pair.
On the other hand, the peptide II showed no notable SPR
signal, indicating that the binding ability of His74-Glu89 se-
quence alone with eIF4E is considerably low. However, it is
obvious that the coexistence of the Thr46-Thr70 and His74-
Glu89 sequences of 4EBP2 is indispensable for revealing the
intact interaction between 4EBP2 and eIF4E, because the KD
of Nd45/Cd31-4EBP2 is about three orders of magnitude low-
er than that of peptide I. Therefore, it could say the supportive
role of the His74-Glu89 sequence in the primary binding of the
Thr46-Thr70 sequence including Y(X)4L/ binding motif to
eIF4E, where the auxiliary eﬀect of His74-Glu89 sequence is
suﬃciently eﬀective to elevate the interaction to a KD of
109.
The eIF4E-binding regulation by 4EBP has been performed
via the competitive binding with eIF4G to a common surface
of eIF4E [7]. Therefore, it is interesting to examine how
strongly peptide III, which is the Gly632-Thr647 sequence of
human eIF4GI (see Fig. 1) and also corresponds to the 474–
489 sequence of yeast eIF4G, associates with eIF4E. The result
showed no notable interaction with eIF4E (Table 1), indicating
the lack of the binding site of eIF4E speciﬁc for peptide III, as
well as for peptide II.
3.4. Possible binding site of 4EBP2 His74–Glu89 sequence to
eIF4E
Previously, Gross et al. [12] determined the solution struc-
ture of the yeast m7GDP-bound eIF4E–eIF4G fragment
(393–490) complex. As the Thr46–Glu89 sequence of human
Fig. 3. MD-simulated overall structure of interaction between eIF4E
(green) and 4EBP2 (red) fragment at 3 ns. The molecules are shown
using the ribbon and wire model, and m7GpppA is shown using the
stick model. H1 and S2 on eIF4E denote the S2-sheet and H1-helix
secondary structures shown in [11]. The N-term indicates the N-
terminal side of eIF4E. The starting structure was constructed with use
of yeast eIF4G (1RF8) as a template.
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the MD simulation of human 4EBP2 Thr46–Glu89 se-
quence—m7GTP-bound human eIF4E complex in an aqueous
solution was performed. Consequently, it was suggested the
stable binding of the Cys73-Glu89 sequence of 4EBP2 at the
root (Ile35-Pro38) of N-terminal ﬂexible region of eIF4E
through the relatively weak hydrophobic interactions. As the
Arg51-Ser65 sequence including the Y(X)4L/ consensus re-
gion stably binds to the 4EBP-binding site of eIF4E via hydro-
gen bond and hydrophobic interactions as previously shown
[11], the overall Thr46-Glu89 sequence of 4EBP2 results in a
right-handed helical ring formation (Fig. 3); similar bracelet
formation was observed in the solution for the 393–490 se-
quence of yeast eIF4G [12]. Because this MD simulation ex-
plains well the present SPR results, it may say that a
function of His74-Glu89 sequence is to strengthen the binding
of the Y(X)4L/ consensus region to the eIF4E-binding site.
In this work, we showed for the ﬁrst time that the C-terminal
His74-Glu89 region of 4EBP2 acts as an auxiliary function for
the major binding of Y(X)4L/ -binding motif (Tyr54-Leu60)
to eIF4E. Previously, Marcotrigiano et al. [10] reported that
the N-terminal 50 and C-terminal 51 amino acids of 4EBP1
are dispensable for eIF4E binding, although the 51–67 se-
quence including Y(X)4L/ -binding motif is essential for the
binding. However, the present result suggests the auxiliary role
of C-terminal Asp74-Asp87 sequence of 4EBP1, because the
comparison of the amino acid sequences of 4EBP1–4EBP3
suggests that 4EBP1 and 4EBP3 have similar eIF4E-binding
sequences (shown in red in Fig. 1a). Indeed, the same authors[10] reported that the deletion of C-terminal 34–51 sequence of
4EBP1 lowers the binding with eIF4E by 25%, while the dele-
tion of the C-terminal 34 residues did not inﬂuence the bind-
ing. The collaborative binding of 4EBP central Y(X)4L/
major binding region and C-terminal auxiliary region to eIF4E
would strengthen the association and prevent the release of
4EBP from its eIF4E complex, and this may be one reason
the hyperphosphorylation, but not hypophosphorylation, of
4EBP Thr and Ser residues is required for dissociation from
eIF4E [9]. The present results provide new important informa-
tion on eIF4E-binding regulation by 4EBP isoform.
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